2005Unpublished venueRequires access

Antibacterial Activity of Cefdinir and Other Four Antimicrobials Against Streptococcus pneumoniae

Rui Wang

Open publisher page 0 citations

Abstract

OBJECTIVE To evaluate the antibacterial activity of cefdinir and other four antimicrobials against 95 strains of Streptococcus pneumoniae in vitro. METHODS Minimal inhibitory concentrations (MIC) were ~determined by dilution method according to NCCLs. RESULTS Penicillin sensitive S. pneumoniae showed the highest susceptibility to cefdinir with susceptible rate of 98.44%, but were resistant to ciprofloxacin. ~S. pneumoniae except penicillin sensitive strains showed highest susceptibility to gatifloxacin with over 90% ~susceptiblility, and also showed good susceptibility to cefdinir and levofloxacin, but were risistant to cefaclor and ciprofloxaoin with susceptible rate of 61.55% and 46.38%. CONCLUSIONS Cefdinir has an powerful antibacterial activity against S. pneumoniae and it is valuable to treat S. pneumoniae infection. The new fluoroquinolones have better antibacterial activity to S. pneumoniae including PISP and PRSP and they can be of the first choice to treat S. pneumoniae infection.

About this research paper

What this paper is about

OBJECTIVE To evaluate the antibacterial activity of cefdinir and other four antimicrobials against 95 strains of Streptococcus pneumoniae in vitro. METHODS Minimal inhibitory concentrations (MIC) were ~determined by dilution method according to NCCLs. RESULTS Penicillin sensitive S. pneumoniae showed the highest susceptibility to cefdinir with susceptible rate of 98.44%, but were resistant to ciprofloxacin. ~S. pneumoniae except penicillin sensitive strains showed highest susceptibility to gatifloxacin with over 90% ~susceptiblility, and also showed good susceptibility to cefdinir and levofloxacin, but were risistant to cefaclor and ciprofloxaoin with susceptible rate of 61.55% and 46.38%. CONCLUSIONS Cefdinir has an powerful antibacterial activity against S. pneumoniae and it is valuable to treat S. pneumoniae infection. The new fluoroquinolones have better antibacterial activity to S. pneumoniae including PISP and PRSP and they can be of the first choice to treat S. pneumoniae infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To evaluate the antibacterial activity of cefdinir and other four antimicrobials against 95 strains of Streptococcus pneumoniae in vitro. METHODS Minimal inhibitory concentrations (MIC) were ~determined by dilution method according to NCCLs. RESULTS Penicillin sensitive S. pneumoniae showed the highest susceptibility to cefdinir with susceptible rate of 98.44%, but were resistant to ciprofloxacin. ~S. pneumoniae except penicillin sensitive strains showed highest susceptibility to gatifloxacin with over 90% ~susceptiblility, and also showed good susceptibility to cefdinir and levofloxacin, but were risistant to cefaclor and ciprofloxaoin with susceptible rate of 61.55% and 46.38%. CONCLUSIONS Cefdinir has an powerful antibacterial activity against S. pneumoniae and it is valuable to treat S. pneumoniae infection. The new fluoroquinolones have better antibacterial activity to S. pneumoniae including PISP and PRSP and they can be of the first choice to treat S. pneumoniae infection.

Key concepts: Cefdinir, Gatifloxacin, Streptococcus pneumoniae, Levofloxacin, Microbiology, Penicillin, Minimum inhibitory concentration, Ciprofloxacin

Related papers

Back to paper searchBrowse research topicsOriginal source
Antibacterial Activity of Cefdinir and Other Four Antimicrobials Against Streptococcus pneumoniae — Research Paper | ScholarLens